KARACHI (PR) - Getz Pharma presented latest clinical data on Unipeg (Pegylated Interferon) at the International Conference on Viral Hepatitis (ICVH) 2013 held recently in New York, USA. This is the first time ever that a Pakistan manufactured biologic product’s clinical trial was accepted and presented at the prestigious ICVH and having the dual distinction of being presented earlier at EASL (European Association of Liver Diseases) conference 2012.

The World famous Icahn School of Medicine at Mount Sinai in New York and the International Association of Providers of AIDS Care (IAPAC) jointly sponsored The International Conference on Viral Hepatitis 2013. It was held at the New York Academy of Medicine in New York City.

The conference was co-chaired by Professor Douglas T Dieterich, MD (Icahn School of Medicine at Mount Sinai, New York, USA) and Professor Mark R Nelson, MD (Chelsea & Westminster Hospital, London, England).

Dr Saleem Qureshi, Co-Investigator EUROP Trial from KRL Hospital Islamabad presented Getz Pharma’s Clinical Trial findings at the conference which was well received by the audience & faculty at the ICVH 2013. The abstract was also published in the ICVH 2013 program & abstract book.